Product Description
Mechanisms of Action: Calcium Binder
Novel Mechanism: Yes
Modality: N/A
Route of Administration: Intravenous
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Chinese Academy of Medical Sciences
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|---|---|---|---|---|
ChiCTR2400083281 | N/A |
Recruiting |
Kidney Transplant |
2024-10-31 |
|
CTR20202533 | N/A |
Not yet recruiting |
Liver Cancer|Gastrointestinal Cancer |
None |